Theseus Pharmaceuticals

Theseus Pharmaceuticals is a company listed under the stock ticker THRX (US).

View the org chart displaying its 17 main executives

Most searched biographies at Theseus Pharmaceuticals

• Don Hayden, Director
• Michael Rome, Director
• Carl Gordon, Director

Popular executive movements at Theseus Pharmaceuticals

• David Kerstein, Chief Medical Officer, will leave the company on Dec. 7, 2023  (posted on December 5 2023).
• Tim Clackson, Chief Executive Officer and Director, will retire on Dec. 7, 2023  (posted on December 5 2023).

Create your alert
to follow the executive moves at Theseus Pharmaceuticals.

Theseus Pharmaceuticals has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Theseus Pharmaceuticals

Social media about Theseus Pharmaceuticals

• Theseus Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Theseus Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Carl Gordon

Call Theseus Pharmaceuticals at +1 212...

View the org chart

Register to receive your alert

Report an error